Health Technology · Pharmaceuticals: Major · NSE: SANOFICONR · data 2026-10-09
Sanofi Consumer Healthcare India Limited
Health check: Strong (6.6/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹3,581.7
Market cap
₹8,277 cr
P/E
31
P/B
23.7
ROE
73.1%
ROCE
82.8%
Debt / equity
0.06
Dividend yield
2.09%
1-year return
-25.8%
52-week high
₹5,255
52-week low
₹3,540
Operating margin
35.8%
Growth
| Revenue (last 12 months) | ₹950 cr |
| Net profit (last 12 months) | ₹266 cr |
| Sales growth, 3 years (yearly) | — |
| Profit growth, 3 years (yearly) | — |
Similar companies
Procter & Gamble Health Ltd. (PGHL) · Suven Life Sciences Limited (SUVEN) · Aarti Pharmalabs Limited (AARTIPHARM) · Morepen Laboratories Limited (MOREPENLAB) · Bliss GVS Pharma Limited (BLISSGVS)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SANOFICONR in NSE Scanner →